OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates

Company Performance - OraSure Technologies reported a quarterly loss of $0.06 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.02, and a significant decline from earnings of $0.22 per share a year ago, representing an earnings surprise of -200% [1] - The company posted revenues of $37.45 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2.27%, but down from $75.88 million in the same quarter last year [2] - Over the last four quarters, OraSure has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - OraSure shares have increased approximately 10.5% since the beginning of the year, outperforming the S&P 500's gain of 1.7% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $32.72 million, and for the current fiscal year, it is -$0.13 on revenues of $146.24 million [7] Industry Outlook - The Medical - Products industry, to which OraSure belongs, is currently ranked in the top 33% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]